डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - ethinylestradiol, gestoden - overtrukne tabletter - 75+30 mikrogram

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - desogestrel, ethinylestradiol - tabletter - 150+30 mikrogram

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

takeda pharma a/s - brigatinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

pfizer europe ma eeig - lorlatinib - carcinom, ikke-småcellet lunge - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

ascend gmbh - natriumoxybat - oral opløsning - 500 mg/ml

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

kalceks as - natriumoxybat - oral opløsning - 500 mg/ml

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

laboratorio reig jofre s.a. - natriumoxybat - oral opløsning - 500 mg/ml

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - sleep apnea, obstructive - andre narkotika stoffer - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 0,10+0,02 mg